BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33768497)

  • 1. Successful transcatheter aortic valve in valve implantation for degenerated trifecta bioprosthesis in a patient with a coronary anomaly.
    Yamagata A; Domoto S; Tanaka K; Inagaki Y; Otsuki H; Hayakawa M; Yamaguchi J; Hagiwara N; Niinami H
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1137-1139. PubMed ID: 33768497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guide Extension-Assisted Stent Implantation at Ostial Right Coronary Artery Creating Stent Tunnel During Transcatheter Aortic Valve Replacement.
    Kanei Y; Qureshi W; Walker J; Kakouros N
    Cardiovasc Revasc Med; 2020 Nov; 21(11S):50-53. PubMed ID: 32473909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Undersizing of Transcatheter Aortic Valve Bioprostheses during Valve-in-Valve Implantation Avoid Coronary Obstruction? An In Vitro Study.
    Stock S; Scharfschwerdt M; Meyer-Saraei R; Richardt D; Charitos EI; Sievers HH; Hanke T
    Thorac Cardiovasc Surg; 2017 Apr; 65(3):218-224. PubMed ID: 27304222
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro coronary flow after transcatheter aortic valve-in-valve implantation: A comparison of 2 valves.
    Stock S; Scharfschwerdt M; Meyer-Saraei R; Richardt D; Charitos EI; Sievers HH; Hanke T
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):255-263.e1. PubMed ID: 28104190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves.
    AlBadri A; Joseph J; Patel V; Patel D; Koren O; Cheng W; Jilaihawi H; Makkar R
    JACC Cardiovasc Interv; 2023 Mar; 16(5):542-554. PubMed ID: 36922040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
    Duncan A; Mirsadree S; Quarto C; Davies S
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):228-235. PubMed ID: 31854041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death after valve-in-valve procedure due to delayed coronary obstruction: a case report.
    Buscaglia A; Tini G; Bezante GP; Brunelli C; Balbi M
    J Med Case Rep; 2018 Sep; 12(1):247. PubMed ID: 30180890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Schäfer U; Kalbacher D; Voigtländer L; Conradi L
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1453-1457. PubMed ID: 29359506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Ye J; Lee AJ; Blanke P; Webb J
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1209-1214. PubMed ID: 29602249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses.
    Van Linden A; Blumenstein J; Möllmann H; Kim WK; Walther T; Kempfert J
    Ann Thorac Surg; 2014 Nov; 98(5):1809-13. PubMed ID: 25441789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall.
    Laricchia A; Mangieri A; Gallo F; Latib A; Fisicaro A; Conti R; Squeri A; Mantovani L; Colombo A; Giannini F
    Cardiovasc Revasc Med; 2020 Nov; 21(11S):18-20. PubMed ID: 31669110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry.
    Sathananthan J; Murdoch DJ; Lindman BR; Zajarias A; Jaber WA; Cremer P; Wood D; Moss R; Cheung A; Ye J; Hahn RT; Crowley A; Leon MB; Mack MJ; Webb JG
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1154-1160. PubMed ID: 29929637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Valve-in-valve treatment of a degenerated supra-annular stentless bioprosthesis using a balloon-expandable transcatheter valve in a patient at high risk for coronary occlusion].
    Mauri S; Ferlini M; Aiello ML; Lanzarini LF; Raviola E; Gazzoli F; Maurelli M; Ferrario M
    G Ital Cardiol (Rome); 2017 Oct; 18(10):734-737. PubMed ID: 29105688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cause of severe transvalvular eccentric jet AR: early structure valve deterioration of Trifecta valves by flail leaflet undergoing valve-in-valve transcatheter aortic valve replacement.
    Chatlaong T; Kosum P; Tumkosit M; Limjareon T
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38395470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.
    Khan JM; Dvir D; Greenbaum AB; Babaliaros VC; Rogers T; Aldea G; Reisman M; Mackensen GB; Eng MHK; Paone G; Wang DD; Guyton RA; Devireddy CM; Schenke WH; Lederman RJ
    JACC Cardiovasc Interv; 2018 Apr; 11(7):677-689. PubMed ID: 29622147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon valuloplasty prior to transcatheter valve-in-valve implantation in a degenerated Mitroflow aortic bioprosthesis.
    Cerillo AG; Berti S; Glauber M
    Catheter Cardiovasc Interv; 2013 May; 81(6):1075-8. PubMed ID: 22744728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Assessment of Coronary Obstruction During Transcatheter Aortic Valve Replacement: Insights From Post-BASILICA Computed Tomography.
    Kitamura M; Wilde J; Dumpies O; Richter I; Obradovic D; Krieghoff C; Gohmann RF; Majunke N; Desch S; Gutberlet M; Borger M; Marwan M; Thiele H; Holzhey D; Abdel-Wahab M
    JACC Cardiovasc Interv; 2022 Mar; 15(5):496-507. PubMed ID: 35272774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the SAPIEN 3 Transcatheter Heart Valve in High-Risk Scenarios.
    Nascimbene A; McAlister C; Yo D; Matejin S; Jezovnik M; Gregoric ID; Kar B
    Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36223247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.
    Duncan A; Moat N; Simonato M; de Weger A; Kempfert J; Eggebrecht H; Walton A; Hellig F; Kornowski R; Spargias K; Mendiz O; Makkar R; Guerrero M; Rihal C; George I; Don C; Iadanza A; Bapat V; Welsh R; Wijeysundera HC; Wood D; Sathananthan J; Danenberg H; Maisano F; Garcia S; Gafoor S; Nombela-Franco L; Cobiella J; Dvir D
    JACC Cardiovasc Interv; 2019 Jul; 12(13):1256-1263. PubMed ID: 31202944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta Bioprosthesis.
    Verhoye JP; Harmouche M; Soulami RB; Thebault C; Boulmier D; Leguerrier A; Anselmi A
    J Heart Valve Dis; 2015 Jul; 24(4):484-6. PubMed ID: 26897821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.